PL1753760T3 - (4-metoksy-7-morffolin-4-ylobenzatiazol-2-ilo)amid kwasu 4-hydroksy-4-metylopiperydyno-1-karboksylowego - Google Patents

(4-metoksy-7-morffolin-4-ylobenzatiazol-2-ilo)amid kwasu 4-hydroksy-4-metylopiperydyno-1-karboksylowego

Info

Publication number: PL1753760T3
Authority: PL; Poland
Prior art keywords: benzothiazol; morpholin; piperidine; methoxy; amide
Prior art date: 2004-05-24

Application number

PL05741185T

Other languages

English (en)

Inventor

Alexander Flohr

Jean-Luc Moreau

Sonia Maria Poli

Claus Riemer

Lucinda Steward

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-24

Filing date

2005-05-17

Publication date

2008-06-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967309&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1753760(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-05-17 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2008-06-30 Publication of PL1753760T3 publication Critical patent/PL1753760T3/pl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL05741185T 2004-05-24 2005-05-17 (4-metoksy-7-morffolin-4-ylobenzatiazol-2-ilo)amid kwasu 4-hydroksy-4-metylopiperydyno-1-karboksylowego PL1753760T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP04102262		2004-05-24
EP05741185A EP1753760B1 (en)	2004-05-24	2005-05-17	4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
PCT/EP2005/005329 WO2005116026A1 (en)	2004-05-24	2005-05-17	4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide

Publications (1)

Publication Number	Publication Date
PL1753760T3 true PL1753760T3 (pl)	2008-06-30

Family

ID=34967309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05741185T PL1753760T3 (pl)	2004-05-24	2005-05-17	(4-metoksy-7-morffolin-4-ylobenzatiazol-2-ilo)amid kwasu 4-hydroksy-4-metylopiperydyno-1-karboksylowego

Country Status (39)

Country	Link
US (1)	US7368446B2 (pl)
EP (1)	EP1753760B1 (pl)
JP (1)	JP4668265B2 (pl)
CN (1)	CN1956983B (pl)
AR (1)	AR048973A1 (pl)
AT (1)	ATE382619T1 (pl)
AU (1)	AU2005247567B2 (pl)
BR (1)	BRPI0511543B1 (pl)
CA (1)	CA2567703C (pl)
CR (1)	CR8703A (pl)
CY (1)	CY1108104T1 (pl)
DE (1)	DE602005004142T2 (pl)
DK (1)	DK1753760T3 (pl)
DO (1)	DOP2005000091A (pl)
EA (1)	EA011279B1 (pl)
EC (1)	ECSP067018A (pl)
ES (1)	ES2297710T3 (pl)
GT (1)	GT200500124A (pl)
HK (1)	HK1105199A1 (pl)
HN (1)	HN2005000238A (pl)
HR (1)	HRP20080027T3 (pl)
IL (1)	IL179364A (pl)
MA (1)	MA28601B1 (pl)
MX (1)	MXPA06013417A (pl)
MY (1)	MY140011A (pl)
NO (1)	NO336939B1 (pl)
NZ (1)	NZ550763A (pl)
PA (1)	PA8633901A1 (pl)
PE (1)	PE20060274A1 (pl)
PL (1)	PL1753760T3 (pl)
PT (1)	PT1753760E (pl)
RS (1)	RS50574B (pl)
SI (1)	SI1753760T1 (pl)
SV (1)	SV2006002125A (pl)
TN (1)	TNSN06371A1 (pl)
TW (1)	TWI358297B (pl)
UA (1)	UA87142C2 (pl)
WO (1)	WO2005116026A1 (pl)
ZA (1)	ZA200609136B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE521512C2 (sv) *	2001-06-25	2003-11-11	Niconovum Ab	Anordning för administrering av en substans till främre delen av en individs munhåla
EP3473251B1 (en) *	2002-12-20	2023-12-13	NicoNovum AB	A nicotine-cellulose combination
WO2007104573A2 (en)	2006-03-16	2007-09-20	Niconovum Ab	Improved snuff composition
MX2010000938A (es) *	2007-07-23	2010-07-01	Synosia Therapeutics Inc	Uso de (4-metoxi-7-morfolin-4-il-benzotiazol-2-il)-amida del ácido 4-hidroxi-4-metil-piperidin-1-carboxílico para el tratamiento del trastorno por estrés postraumático.
GEP20135992B (en)	2009-01-12	2013-12-25	Icagen Inc	Sulfonamide derivatives
US8168785B2 (en)	2009-06-17	2012-05-01	Biotie Therapies, Inc.	Benzothiazole derivatives
WO2011101861A1 (en)	2010-01-29	2011-08-25	Msn Laboratories Limited	Process for preparation of dpp-iv inhibitors
ES2532356T3 (es)	2010-07-09	2015-03-26	Pfizer Limited	N-sulfonilbenzamidas como inhibidores de los canales de sodio dependientes de voltaje
WO2012060844A1 (en) *	2010-11-05	2012-05-10	Biotie Therapies, Inc	A2a antagonists as cognition and motor function enhancers
JP6042968B2 (ja) *	2012-04-20	2016-12-14	ユセベファルマソシエテアノニム	パーキンソン病の処置方法
WO2016204939A1 (en) *	2015-06-19	2016-12-22	Biotie Therapies, Inc.	Controlled-release tozadenant formulations
WO2018059531A1 (zh) *	2016-09-30	2018-04-05	苏州晶云药物科技有限公司	一种腺苷a2a受体拮抗剂药物的晶型及其制备方法和用途
IL272637B2 (en)	2017-08-21	2024-03-01	Merck Patent Gmbh	History of benzaimidazole, their preparation and medicines containing them
IL272638B2 (en) *	2017-08-21	2024-05-01	Merck Patent Gmbh	History of quinoxaline, their preparation and pharmaceutical preparations containing them
WO2019141096A1 (zh) *	2018-01-19	2019-07-25	四川科伦博泰生物医药股份有限公司	取代脲类化合物及其制备方法和用途
CA3123856A1 (en)	2018-12-20	2020-06-25	Biotie Therapies, Inc.	Methods for treating cancer using tozadenant
DE102019110904B4 (de)	2019-04-26	2022-01-20	Helmholtz-Zentrum Dresden - Rossendorf E. V.	N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH505543A (de)	1968-11-01	1971-04-15	Ciba Geigy Ag	Schädlingsbekämpfungsmittel
NL7109150A (pl)	1970-07-06	1972-01-10
US4028374A (en) *	1975-11-03	1977-06-07	Morton-Norwich Products, Inc.	Antibacterial thiocyanatobenzothiazoles
DE2656468A1 (de)	1976-12-14	1978-06-15	Boehringer Mannheim Gmbh	N-(benzthiazol-2-yl)-oxamidsaeure- derivate und verfahren zu ihrer herstellung
KR930005004B1 (ko)	1985-04-15	1993-06-11	쟈안센 파아마슈우티카 엔. 부이.	치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
FI91859C (fi)	1987-06-17	1994-08-25	Eisai Co Ltd	Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
IL90337A0 (en)	1988-05-24	1989-12-15	Pfizer	Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
WO1990015801A1 (en)	1989-06-22	1990-12-27	Pfizer Inc.	Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases
EP0427963B1 (de) *	1989-11-10	1994-03-30	Agrolinz Agrarchemikalien Gesellschaft M.B.H.	Verfahren zur Herstellung reiner, unsymmetrisch disubstituierter Harnstoffe
WO1993023409A1 (en)	1992-05-21	1993-11-25	Otsuka Pharmaceutical Factory, Inc.	Phosphonic diester derivative
FR2753970B1 (fr)	1996-10-01	1998-10-30	Synthelabo	Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
JPH11130761A (ja)	1997-10-24	1999-05-18	Otsuka Pharmaceut Co Ltd	ベンゾチアゾール誘導体
AU744281B2 (en)	1997-11-10	2002-02-21	Bristol-Myers Squibb Company	Benzothiazole protein tyrosine kinase inhibitors
KR20010015910A (ko)	1998-01-23	2001-02-26	로렌스 티. 마이젠헬더	옥사졸리디논 조합 라이브러리, 조성물 및 제조 방법
WO2000018767A2 (en)	1998-09-30	2000-04-06	Neurogen Corporation	2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
GB9824579D0 (en) *	1998-11-10	1999-01-06	Novartis Ag	Organic compounds
UA71587C2 (uk)	1998-11-10	2004-12-15	Шерінг Акцієнгезелльшафт	Аміди антранілової кислоти та їхнє застосування як лікарських засобів
IL133680A0 (en)	1999-09-10	2001-04-30	Can Fite Technologies Ltd	Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
DE60023949T2 (de)	2000-05-12	2006-08-10	Corning Inc.	Verfahren zum herstellen einer vorform mit schutzumhüllung für optische fasern
IL153278A0 (en) *	2000-06-21	2003-07-06	Hoffmann La Roche	Benzothiazole derivatives
US6727247B2 (en) *	2001-12-10	2004-04-27	Hoffman-La Roche Inc.	Substituted benzothiazole amide derivatives
US6713499B2 (en) *	2001-12-12	2004-03-30	Hoffman-La Roche Inc.	7-Amino-benzothiazole derivatives

2005
- 2005-05-17 EA EA200602048A patent/EA011279B1/ru not_active IP Right Cessation
- 2005-05-17 CN CN200580016875XA patent/CN1956983B/zh not_active Expired - Fee Related
- 2005-05-17 BR BRPI0511543-4A patent/BRPI0511543B1/pt not_active IP Right Cessation
- 2005-05-17 UA UAA200613530A patent/UA87142C2/ru unknown
- 2005-05-17 EP EP05741185A patent/EP1753760B1/en active Active
- 2005-05-17 SI SI200530160T patent/SI1753760T1/sl unknown
- 2005-05-17 DE DE602005004142T patent/DE602005004142T2/de active Active
- 2005-05-17 AT AT05741185T patent/ATE382619T1/de active
- 2005-05-17 JP JP2007513750A patent/JP4668265B2/ja not_active Expired - Fee Related
- 2005-05-17 PL PL05741185T patent/PL1753760T3/pl unknown
- 2005-05-17 WO PCT/EP2005/005329 patent/WO2005116026A1/en active Application Filing
- 2005-05-17 PT PT05741185T patent/PT1753760E/pt unknown
- 2005-05-17 AU AU2005247567A patent/AU2005247567B2/en active Active
- 2005-05-17 CA CA2567703A patent/CA2567703C/en active Active
- 2005-05-17 NZ NZ550763A patent/NZ550763A/en not_active IP Right Cessation
- 2005-05-17 RS RSP-2008/0125A patent/RS50574B/sr unknown
- 2005-05-17 ES ES05741185T patent/ES2297710T3/es active Active
- 2005-05-17 MX MXPA06013417A patent/MXPA06013417A/es active IP Right Grant
- 2005-05-17 DK DK05741185T patent/DK1753760T3/da active
- 2005-05-18 US US11/132,019 patent/US7368446B2/en active Active
- 2005-05-20 DO DO2005000091A patent/DOP2005000091A/es unknown
- 2005-05-20 MY MYPI20052309A patent/MY140011A/en unknown
- 2005-05-20 TW TW094116495A patent/TWI358297B/zh not_active IP Right Cessation
- 2005-05-23 GT GT200500124A patent/GT200500124A/es unknown
- 2005-05-23 PA PA20058633901A patent/PA8633901A1/es unknown
- 2005-05-23 AR ARP050102104A patent/AR048973A1/es not_active Application Discontinuation
- 2005-05-23 PE PE2005000569A patent/PE20060274A1/es active IP Right Grant
- 2005-05-23 HN HN2005000238A patent/HN2005000238A/es unknown
- 2005-05-24 SV SV2005002125A patent/SV2006002125A/es unknown
2006
- 2006-10-24 CR CR8703A patent/CR8703A/es unknown
- 2006-11-02 ZA ZA200609136A patent/ZA200609136B/xx unknown
- 2006-11-14 TN TNP2006000371A patent/TNSN06371A1/fr unknown
- 2006-11-16 IL IL179364A patent/IL179364A/en active IP Right Grant
- 2006-11-21 EC EC2006007018A patent/ECSP067018A/es unknown
- 2006-11-22 MA MA29481A patent/MA28601B1/fr unknown
- 2006-12-12 NO NO20065732A patent/NO336939B1/no not_active IP Right Cessation
2007
- 2007-09-27 HK HK07110484.5A patent/HK1105199A1/xx not_active IP Right Cessation
2008
- 2008-01-18 HR HR20080027T patent/HRP20080027T3/xx unknown
- 2008-02-28 CY CY20081100232T patent/CY1108104T1/el unknown

Also Published As

Publication number	Publication date
PA8633901A1 (es)	2006-05-16
TW200612937A (en)	2006-05-01
US20050261289A1 (en)	2005-11-24
JP4668265B2 (ja)	2011-04-13
EA200602048A1 (ru)	2007-06-29
DE602005004142D1 (de)	2008-02-14
ES2297710T3 (es)	2008-05-01
HK1105199A1 (en)	2008-02-06
HN2005000238A (es)	2008-07-14
MY140011A (en)	2009-11-30
AU2005247567A1 (en)	2005-12-08
DOP2005000091A (es)	2005-06-29
CA2567703C (en)	2013-03-05
CR8703A (es)	2007-10-04
IL179364A0 (en)	2007-03-08
CN1956983B (zh)	2010-05-26
ATE382619T1 (de)	2008-01-15
AR048973A1 (es)	2006-06-14
ECSP067018A (es)	2006-12-29
UA87142C2 (en)	2009-06-25
PE20060274A1 (es)	2006-04-14
TWI358297B (en)	2012-02-21
NZ550763A (en)	2010-07-30
MXPA06013417A (es)	2007-01-23
DE602005004142T2 (de)	2009-01-02
EA011279B1 (ru)	2009-02-27
JP2008500295A (ja)	2008-01-10
NO20065732L (no)	2006-12-22
TNSN06371A1 (fr)	2008-02-22
BRPI0511543A (pt)	2008-01-02
US7368446B2 (en)	2008-05-06
SV2006002125A (es)	2006-02-15
EP1753760B1 (en)	2008-01-02
NO336939B1 (no)	2015-11-30
CY1108104T1 (el)	2014-02-12
MA28601B1 (fr)	2007-05-02
SI1753760T1 (sl)	2008-04-30
EP1753760A1 (en)	2007-02-21
DK1753760T3 (da)	2008-04-14
AU2005247567B2 (en)	2010-09-02
CA2567703A1 (en)	2005-12-08
CN1956983A (zh)	2007-05-02
HRP20080027T3 (en)	2008-05-31
PT1753760E (pt)	2008-02-12
RS50574B (sr)	2010-05-07
ZA200609136B (en)	2008-07-30
BRPI0511543B1 (pt)	2022-05-10
WO2005116026A1 (en)	2005-12-08
IL179364A (en)	2013-01-31
GT200500124A (es)	2005-12-26

Publication	Publication Date	Title
ZA200609136B (en)	2008-07-30	4-Hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
IL241732B (en)	2019-10-31	2-di-tert-butyloxycarbonylamino-6-bromo-9-(2-trimethylsilylethoxy)methyl-h9-purine
ZA200609595B (en)	2008-06-25	Novel CIS-Imidazolines
IL179730A0 (en)	2007-05-15	Novel cis-imidazolines
TWI372750B (en)	2012-09-21	Novel hydroxy-6-heteroarylphenanthridines
ZA200704636B (en)	2008-09-25	2-alkyl-cycloalk(en)yl-carboxamides
ZA200610303B (en)	2010-05-26	Novel cis-imidazolines
GB0414026D0 (en)	2004-07-28	Novel uses
ZA200804845B (en)	2009-05-27	Bubbling brick
ZA200606635B (en)	2008-05-28	Novel isoamido-substituted hydroxy-6-phenylphenanthridines
GB0408865D0 (en)	2004-05-26	Novel benzoxazocines
GB0400329D0 (en)	2004-02-11	Novel processes
GB0400382D0 (en)	2004-02-11	Novel processes
GB0420607D0 (en)	2004-10-20	Amino acid
GB0425900D0 (en)	2004-12-29	Novel pyrrolopyridine-2-carboxylic acid amide
GB0416455D0 (en)	2004-08-25	Lo-ro (lotion-roller)
ZA200608482B (en)	2008-04-30	Novel tetrahydropyridothiophenes
GB0408863D0 (en)	2004-05-26	Novel benzoxazocines
GB0408862D0 (en)	2004-05-26	Novel benzoxazocines
GB0505847D0 (en)	2005-04-27	Novel benzoxazocines
AU156233S (en)	2004-08-20	Clear can
GB0400405D0 (en)	2004-02-11	Novel processes
GB0412872D0 (en)	2004-07-14	Novel structures
GB0408300D0 (en)	2004-05-19	Novel inhibitors
GB0420262D0 (en)	2004-10-13	Novel uses